Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$3.06 - $51.61 $688,500 - $11.6 Million
-225,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$31.16 - $48.62 $221,236 - $345,202
7,100 Added 3.26%
225,000 $8.5 Million
Q4 2018

Feb 14, 2019

BUY
$23.33 - $36.37 $942,531 - $1.47 Million
40,400 Added 22.76%
217,900 $7.93 Million
Q3 2018

Nov 14, 2018

BUY
$29.34 - $35.0 $5.21 Million - $6.21 Million
177,500 New
177,500 $6.09 Million

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.